Safety and Efficacy of BRM421 for Dry Eye Syndrome

Clinical trial NCT03066219 · COMPLETED

Trial details

NCT number: NCT03066219
Sponsor: BRIM Biotechnology Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndrome

Start date: 2017-02-07
Primary completion: 2017-05-20
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.